Search

everythinglearnresearchcommunity

for

Search:↓

Some patients with Alopecia Areata experience itch due to immune cells and enzymes that cause itching.

Graft rejection in a hand transplant may trigger hair loss due to autoimmune responses.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Bexarotene gel shows promise as a new treatment for alopecia areata.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Researchers found four genes that could help diagnose severe alopecia areata early.

Certain drugs can cause hair loss, but stopping the drug usually leads to hair regrowth.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

PRP treatment may help with alopecia areata, especially in newer cases.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.

IMA and IMA/albumin levels don't predict alopecia areata severity.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

CAR is a useful marker for assessing alopecia areata severity.

The fractional carbon dioxide laser is a safe and effective treatment for alopecia areata and works better than betamethasone valerate cream alone.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

Patients with alopecia areata have higher oxidative stress and lower antioxidant levels.

A woman developed alopecia after her second Pfizer vaccine but regrew her hair with treatment and had no issues after a booster shot.

People with severe hair loss (Alopecia Areata) have different scalp bacteria than healthy people, which might help predict the condition's progress.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

Low Vitamin D is common in people with Alopecia Areata, but its impact on the condition needs more research.

Hair color is not a risk factor for developing alopecia areata.